Startseite Medizin Development and validation of a candidate reference measurement procedure for free triiodothyronine and free thyroxine in human serum using equilibrium dialysis isotope-dilution liquid chromatography-tandem mass spectrometry
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Development and validation of a candidate reference measurement procedure for free triiodothyronine and free thyroxine in human serum using equilibrium dialysis isotope-dilution liquid chromatography-tandem mass spectrometry

  • Min Zhan , Qiaoxuan Zhang , Zijia Ma , Liqiao Han , Jun Yan , Guangya Zheng , Wenxi Zhou , Weiyan Zhou EMAIL logo und Xianzhang Huang EMAIL logo
Veröffentlicht/Copyright: 18. Dezember 2025

Abstract

Objectives

Free triiodothyronine (FT3) and free thyroxine (FT4) are important diagnostic markers for assessing thyroid function. However, their accurate quantification remains challenging due to low serum concentrations. Significant variability exists among current assay methods for measuring FT3 and FT4. This study aims to establish a candidate Reference Measurement Procedure (cRMP) for simultaneous quantification of serum FT3 and FT4 based on isotope-dilution liquid chromatography-tandem mass spectrometry (ID-LC-MS/MS) technology.

Methods

A convenient and reusable equilibrium dialysis (ED) device was utilized to separate free thyroid hormones from their protein-bound counterparts in serum. Key dialysis parameters, including temperature, pH, membrane type, and duration, were optimized to ensure consistent and reliable performance. The dialysate containing FT3 and FT4 was directly quantified by ID-LC-MS/MS. The method underwent systematic validation, comparative analysis with existing assays, and a comprehensive uncertainty assessment.

Results

The developed cRMP demonstrated limits of quantification (LoQ) of 1.54 pmol/L for FT3 and 3.22 pmol/L for FT4, and with an imprecision of less than 3 %. No interference from endogenous analogs was observed, and the method showed good consistency in interlaboratory comparison. In contrast, chemiluminescent immunoassay results exhibited poor agreement with and the cRMP.

Conclusions

This study developed a highly precise, accurate, specific, and sensitive ID-LC-MS/MS-based cRMP for the simultaneous measurement of FT3 and FT4 in human serum. This method provides a reliable tool for standardizing routine thyroid function tests.


Corresponding authors: Weiyan Zhou, National Center for Clinical Laboratories, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing Hospital/National Center of Gerontology, No. 1, Dahua Road, Dongcheng District, Beijing 100730, P.R. China, E-mail: ; and Xianzhang Huang, Department of Laboratory Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, P.R. China, E-mail:
Min Zhan and Qiaoxuan Zhang contributed equally to this work.

Funding source: The National Key Technologies R&D Program of China

Award Identifier / Grant number: 2022YFC3602302

Funding source: National High Level Hospital Clinical Research Funding

Award Identifier / Grant number: BJ-2025-136

Funding source: the Specific Research Fund for TCM Science and Technology of Guangdong Provincial Hospital of Chinese Medicine

Award Identifier / Grant number: YN2023QN07

Funding source: Guangdong Provincial Clinical Research Center for Laboratory Medicine

Award Identifier / Grant number: 2023B110008

  1. Research ethics: The collection of leftover serum samples was approved by the Ethics Committee of the Second Affiliated Hospital of Guangzhou University of Chinese Medicine (No. ZE2022-331-01).

  2. Informed consent: Because leftover samples involved in this study were anonymous, the ethics committee allowed the exemption of informed consent.

  3. Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  4. Use of Large Language Models, AI and Machine Learning Tools: None declared.

  5. Conflict of interest: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

  6. Research funding: This work was supported by the National Key Technologies R&D Program of China (2022YFC3602302); National High Level Hospital Clinical Research Funding (BJ-2025-136); the Specific Research Fund for TCM Science and Technology of Guangdong Provincial Hospital of Chinese Medicine (YN2023QN07); Guangdong Provincial Clinical Research Center for Laboratory Medicine (2023B110008).

  7. Data availability: The raw data can be obtained on request from the corresponding author.

References

1. Vanderpump, MP. The epidemiology of thyroid disease. Br Med Bull 2011;99:39–51. https://doi.org/10.1093/bmb/ldr030.Suche in Google Scholar PubMed

2. Taylor, PN, Albrecht, D, Scholz, A, Gutierrez-Buey, G, Lazarus, JH, Dayan, CM, et al.. Global epidemiology of hyperthyroidism and hypothyroidism. Nat Rev Endocrinol 2018;14:301–16. https://doi.org/10.1038/nrendo.2018.18.Suche in Google Scholar PubMed

3. Uppal, N, Collins, R, James, B. Thyroid nodules: global, economic, and personal burdens. Front Endocrinol 2023;14:1113977. https://doi.org/10.3389/fendo.2023.1113977.Suche in Google Scholar PubMed PubMed Central

4. Thienpont, LM, Van Uytfanghe, K, Van Houcke, S. Standardization activities in the field of thyroid function tests: a status report. Clin Chem Lab Med 2010;48:1577–83. https://doi.org/10.1515/cclm.2010.321.Suche in Google Scholar

5. Wang, D, Yu, S, Ma, C, Li, H, Qiu, L, Cheng, X, et al.. Reference intervals for thyroid-stimulating hormone, free thyroxine, and free triiodothyronine in elderly Chinese persons. Clin Chem Lab Med 2019;57:1044–52. https://doi.org/10.1515/cclm-2018-1099.Suche in Google Scholar PubMed

6. Thvilum, M, Brandt, F, Brix, TH, Hegedüs, L. A review of the evidence for and against increased mortality in hypothyroidism. Nat Rev Endocrinol 2012;8:417–24. https://doi.org/10.1038/nrendo.2012.29.Suche in Google Scholar PubMed

7. Van Uytfanghe, K, Ehrenkranz, J, Halsall, D, Hoff, K, Loh, TP, Spencer, CA, et al.. Thyroid stimulating hormone and thyroid hormones (triiodothyronine and thyroxine): an American thyroid association-commissioned review of current clinical and laboratory status. Thyroid 2023;33:1013–28. https://doi.org/10.1089/thy.2023.0169.Suche in Google Scholar PubMed PubMed Central

8. Favresse, J, Burlacu, MC, Maiter, D, Gruson, D. Interferences with thyroid function immunoassays: clinical implications and detection algorithm. Endocr Rev 2018;39:830–50. https://doi.org/10.1210/er.2018-00119.Suche in Google Scholar PubMed

9. Wang, R, Nelson, JC, Weiss, RM, Wilcox, RB. Accuracy of free thyroxine measurements across natural ranges of thyroxine binding to serum proteins. Thyroid 2000;10:31–9. https://doi.org/10.1089/thy.2000.10.31.Suche in Google Scholar PubMed

10. Holm, SS, Hansen, SH, Faber, J, Staun-Olsen, P. Reference methods for the measurement of free thyroid hormones in blood: evaluation of potential reference methods for free thyroxine. Clin Biochem 2004;37:85–93. https://doi.org/10.1016/j.clinbiochem.2003.09.009.Suche in Google Scholar PubMed

11. Steele, BW, Wang, E, Klee, GG, Thienpont, LM, Soldin, SJ, Sokoll, LJ, et al.. Analytic bias of thyroid function tests: analysis of a College of American Pathologists fresh frozen serum pool by 3900 clinical laboratories. Arch Pathol Lab Med 2005;129:310–7. https://doi.org/10.5858/2005-129-310-abotft.Suche in Google Scholar PubMed

12. De Grande, LAC, Van Uytfanghe, K, Reynders, D, Das, B, Faix, JD, MacKenzie, F, et al.. Standardization of free thyroxine measurements allows the adoption of a more uniform reference interval. Clin Chem 2017;63:1642–52. https://doi.org/10.1373/clinchem.2017.274407.Suche in Google Scholar PubMed

13. Thienpont, LM, Faix, JD, Beastall, G. Standardization of free thyroxine and harmonization of thyrotropin measurements: a request for input from endocrinologists and other physicians. Thyroid 2015;25:1379–80. https://doi.org/10.1089/thy.2015.0309.Suche in Google Scholar PubMed PubMed Central

14. Klee, GG. Harmonization and standardization of thyroid function tests. Clin Chem 2010;56:879–80. https://doi.org/10.1373/clinchem.2010.145540.Suche in Google Scholar PubMed

15. Schussler, GC. Thyroxine-binding proteins. Thyroid 1990;1:25–34. https://doi.org/10.1089/thy.1990.1.25.Suche in Google Scholar PubMed

16. Zoeller, RT, Tan, SW, Tyl, RW. General background on the hypothalamic-pituitary-thyroid (HPT) axis. Crit Rev Toxicol 2007;37:11–53. https://doi.org/10.1080/10408440601123446.Suche in Google Scholar PubMed

17. Mullur, R, Liu, YY, Brent, GA. Thyroid hormone regulation of metabolism. Physiol Rev 2014;94:355–82. https://doi.org/10.1152/physrev.00030.2013.Suche in Google Scholar PubMed PubMed Central

18. Midgley, JE. The free thyroid hormone hypothesis and measurement of free hormones. Clin Chem 1993;39:1342–4. https://doi.org/10.1093/clinchem/39.6.1342.Suche in Google Scholar

19. Ekins, R. The free hormone hypothesis and measurement of free hormones. Clin Chem 1992;38:1289–93. https://doi.org/10.1093/clinchem/38.7.1289.Suche in Google Scholar

20. Schussler, GC. The thyroxine-binding proteins. Thyroid 2000;10:141–9. https://doi.org/10.1089/thy.2000.10.141.Suche in Google Scholar PubMed

21. Seifert, J, Chen, Y, Schöning, W, Mai, K, Tacke, F, Spranger, J, et al.. Hepatic energy metabolism under the local control of the thyroid hormone system. Int J Mol Sci 2023;24:4861. https://doi.org/10.3390/ijms24054861.Suche in Google Scholar PubMed PubMed Central

22. Faix, JD. Principles and pitfalls of free hormone measurements. Best Pract Res Clin Endocrinol Metabol 2013;27:631–45. https://doi.org/10.1016/j.beem.2013.06.007.Suche in Google Scholar PubMed

23. CLSI, Clinical Laboratory and Standards Institute. Measurement of free thyroid hormones; approved guideline, in PA: CLSI Document C45-A. Wayne; 2004.Suche in Google Scholar

24. Jansen, HI, van der Steen, R, Brandt, A, Olthaar, AJ, Vesper, HW, Shimizu, E, et al.. Description and validation of an equilibrium dialysis ID-LC-MS/MS candidate reference measurement procedure for free thyroxine in human serum. Clin Chem Lab Med 2023;61:1605–11. https://doi.org/10.1515/cclm-2022-1134.Suche in Google Scholar PubMed

25. Midgley, JE. Direct and indirect free thyroxine assay methods: theory and practice. Clin Chem 2001;47:1353–63. https://doi.org/10.1093/clinchem/47.8.1353.Suche in Google Scholar

26. Thienpont, LM, Van Uytfanghe, K, Beastall, G, Faix, JD, Ieiri, T, Miller, WG, et al.. Report of the IFCC working group for standardization of thyroid function tests; part 2: free thyroxine and free triiodothyronine. Clin Chem 2010;56:912–20. https://doi.org/10.1373/clinchem.2009.140194.Suche in Google Scholar PubMed

27. Thienpont, LM, Beastall, G, Christofides, ND, Faix, JD, Ieiri, T, Miller, WG, et al.. Measurement of free thyroxine in laboratory medicine--proposal of measurand definition. Clin Chem Lab Med 2007;45:563–4. https://doi.org/10.1515/cclm.2007.099.Suche in Google Scholar PubMed

28. Thienpont, LM, Beastall, G, Christofides, ND, Faix, JD, Ieiri, T, Jarrige, V, et al.. Proposal of a candidate international conventional reference measurement procedure for free thyroxine in serum. Clin Chem Lab Med 2007;45:934–6. https://doi.org/10.1515/cclm.2007.155.Suche in Google Scholar

29. Van Houcke, SK, Van Uytfanghe, K, Shimizu, E, Tani, W, Umemoto, M, Thienpont, LM. IFCC international conventional reference procedure for the measurement of free thyroxine in serum: International Federation of clinical chemistry and laboratory medicine (IFCC) working group for standardization of thyroid function tests (WG-STFT)(1). Clin Chem Lab Med 2011;49:1275–81. https://doi.org/10.1515/cclm.2011.639.Suche in Google Scholar

30. Ribera, A, Zhang, L, Dabbs-Brown, A, Sugahara, O, Poynter, K, van Uytfanghe, K, et al.. Development of an equilibrium dialysis ID-UPLC-MS/MS candidate reference measurement procedure for free thyroxine in human serum. Clin Biochem 2023;116:42–51. https://doi.org/10.1016/j.clinbiochem.2023.03.010.Suche in Google Scholar PubMed PubMed Central

31. Tabachnick, M, Korcek, L. Effect of long-chain fatty acids on the binding of thyroxine and triiodothyronine to human thyroxine-binding globulin. Biochim Biophys Acta 1986;881:292–6. https://doi.org/10.1016/0304-4165-86-90016-4.Suche in Google Scholar

32. Nishikawa, M, Ogawa, Y, Yoshikawa, N, Yoshimura, M, Toyoda, N, Shouzu, A, et al.. Plasma free thyroxine (FT4) concentrations during hemodialysis in patients with chronic renal failure: effects of plasma non-esterified fatty acids on FT4 measurement. Endocr J 1996;43:487–93. https://doi.org/10.1507/endocrj.43.487.Suche in Google Scholar PubMed

33. CLSI. Evaluation of precision of quantitative measurement procedures; approved guideline–third edition, in CLSI document EP5-A3. Wayne: Clinical and Laboratory Standards Institute; 2014.Suche in Google Scholar

34. CLSI. Evaluation of linearity of quantitative measurement procedures: a statistical approach; approved guideline, in CLSI document EP6-A. Wayne: Clinical and Laboratory Standards Institute; 2003.Suche in Google Scholar

35. CLSI. Evaluation of detection capability for clinical laboratory measurement procedures, in approved guideline-second edition, in CLSI document EP17-A2. Wayne: Clinical and Laboratory Standards Institute; 2012.Suche in Google Scholar

36. CLSI. Interference testing in clinical chemistry; approved guideline–second edition, in CLSI document EP7-A2. Wayne: Clinical and Laboratory Standards Institute; 2005.Suche in Google Scholar

37. CLSI. Interference testing in clinical chemistry; approved guideline–second edition, in CLSI document C62-A. Wayne: Clinical and Laboratory Standards Institute; 2014.Suche in Google Scholar

38. Thomas, MA. Ion suppression in mass spectrometry. Clin Chem 2003;49:1041–4. https://doi.org/10.1373/49.7.1041.Suche in Google Scholar PubMed

39. Meyer, VR. Measurement uncertainty. J Chromatogr A 2007;1158:15–24. https://doi.org/10.1016/j.chroma.2007.02.082.Suche in Google Scholar PubMed

40. Lang, X, Li, Y, Zhang, D, Zhang, Y, Wu, N, Zhang, Y. FT3/FT4 ratio is correlated with all-cause mortality, cardiovascular mortality, and cardiovascular disease risk: NHANES 2007–2012. Front Endocrinol 2022;13:964822. https://doi.org/10.3389/fendo.2022.964822.Suche in Google Scholar PubMed PubMed Central

41. Zou, Y, Wang, D, Cheng, X, Ma, C, Lin, S, Hu, Y, et al.. Reference intervals for thyroid-associated hormones and the prevalence of thyroid diseases in the Chinese population. Ann Lab Med 2021;41:77–85. https://doi.org/10.3343/alm.2021.41.1.77.Suche in Google Scholar PubMed PubMed Central

42. Ribera, A, Zhang, L, Ribeiro, C, Vazquez, N, Thonkulpitak, J, Botelho, JC, et al.. Practical considerations for accurate determination of free thyroxine by equilibrium dialysis. J Mass Spectrom Adv Clin Lab 2023;29:9–15. https://doi.org/10.1016/j.jmsacl.2023.06.001.Suche in Google Scholar PubMed PubMed Central

43. Ribera, A, Sugahara, O, Buchannan, T, Vazquez, N, Lyle, AN, Zhang, L, et al.. Evaluation of the current state of thyroid hormone testing in human serum-results of the free thyroxine and thyrotropin interlaboratory comparison study. Thyroid 2025;35:471–84. https://doi.org/10.1089/thy.2024.0728.Suche in Google Scholar PubMed

44. Kratzsch, J, Baumann, NA, Ceriotti, F, Lu, ZX, Schott, M, van Herwaarden, AE, et al.. Global FT4 immunoassay standardization: an expert opinion review. Clin Chem Lab Med 2020;59:1013–23. https://doi.org/10.1515/cclm-2020-1696.Suche in Google Scholar PubMed


Supplementary Material

This article contains supplementary material (https://doi.org/10.1515/cclm-2025-0874).


Received: 2025-07-11
Accepted: 2025-12-01
Published Online: 2025-12-18

© 2025 Walter de Gruyter GmbH, Berlin/Boston

Heruntergeladen am 30.12.2025 von https://www.degruyterbrill.com/document/doi/10.1515/cclm-2025-0874/html
Button zum nach oben scrollen